Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Accelerated Phase × olverembatinib × Clear all

NCT03883100 2023-04-03

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Accelerated Phase